[1]谢 昊,董 阳,莫崇念,等.不同程度冠脉病变冠心病患者血清亲环素A、可溶性生长刺激表达基因2蛋白、基质金属蛋白酶-29水平变化及其诊断价值分析[J].陕西医学杂志,2024,(7):949-953.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.018]
　XIE Hao,DONG Yang,MO Chongnian,et al.Changes and diagnostic value of serum CyPA,sST2 and MMP-29 in coronary heart disease patients with different degrees of coronary artery disease[J].,2024,(7):949-953.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.018]
点击复制

不同程度冠脉病变冠心病患者血清亲环素A、可溶性生长刺激表达基因2蛋白、基质金属蛋白酶-29水平变化及其诊断价值分析

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年7期
页码:
949-953
栏目:
临床研究
出版日期:
2024-07-05

文章信息/Info

Title:
Changes and diagnostic value of serum CyPA,sST2 and MMP-29 in coronary heart disease patients with different degrees of coronary artery disease
作者:
谢 昊1; 董 阳2;  莫崇念2; 江 彬2
(1.都江堰市中医医院心血管内科,四川 都江堰611830; 2.都江堰市中医医院心病科,四川 都江堰611830)
Author(s):
XIE Hao; DONG Yang; MO Chongnian; JIANG Bin
(Department of Cardiovascular Medicine,Dujiangyan Hospital of Traditional Chinese Medicine,Dujiangyan 611830,China)
关键词:
冠心病;  冠状动脉;  血清亲环素A;  可溶性生长刺激表达基因2蛋白;  基质金属蛋白酶-29;  诊断价值
Keywords:
Coronary heart disease;  Coronary artery;  Serum cyclophilin A;  Soluble growth stimulation expressed gene 2;  Matrix metalloproteinase-29;  Diagnostic value
分类号:
R 514.4
DOI:
DOI:10.3969/j.issn.1000-7377.2024.07.018
文献标志码:
A
摘要:
目的:分析不同程度冠脉病变冠心病患者血清亲环素A(CyPA)、可溶性生长刺激表达基因2蛋白(sST2)、基质金属蛋白酶-29(MMP-29)水平变化及其诊断价值。方法:收集60例冠心病患者作为冠心病组,另在同一时期内的体检人员中收集50例健康者作为对照组。其中冠心病组经冠脉造影检查后,根据病变类型分为三组,即不稳定心绞痛、稳定性心绞痛以及急性心肌梗死组; 根据病变支数分为三组,即单支病变、双支病变以及三支病变组; 根据Gensini评分分为三组,即轻度病变、中度病变以及重度病变组。比较观察组与对照组血清CyPA、sST2、MMP-29水平; 比较不同疾病类型患者血清CyPA、sST2、MMP-29水平; 比较不同病变支数患者血清CyPA、sST2、MMP-29水平; 比较不同病变程度患者血清CyPA、sST2、MMP-29水平; 分析冠心病患者血清CyPA、sST2、MMP-29水平与病变程度的相关性及诊断价值。结果:观察组血清CyPA、sST2、MMP-29水平高于对照组(均P<0.05); 三组间血清CyPA、sST2、MMP-29水平比较差异有统计学意义,且与稳定性心绞痛组比较,不稳定性心绞痛组、急性心肌梗死组更高,而急性心肌梗死组比较不稳定性心较痛组也更高(均P<0.05); 三组间血清CyPA、sST2、MMP-29水平比较差异有统计学意义,且双支病变组、三支病变组比较单支病变组更高,而三支病变组比较双支病变组也更高(均P<0.05); 三组间血清CyPA、sST2、MMP-29水平比较差异有统计学意义,且与轻度病变组比较,中度病变组、重度病变组更高,而与中度病变组比较,重度病变组更高(均P<0.05); 经Spearman相关性分析显示,冠心病患者血清CyPA、sST2、MMP-29检测值与其病变程度具有正相关关系(均P<0.05); 经ROC曲线分析,血清CyPA诊断冠心病的曲线下面积(AUC)、特异度高于sST2和MMP-29(均P<0.05)。结论:冠心病患者血清CyPA、sST2、MMP-29水平越高,冠脉病变程度越严重,CyPA、sST2、MMP-29可作为冠心病病情诊断及评估的指标之一。
Abstract:
Objective:To analyze the changes and diagnostic value of serum cyclophilin A(CyPA),soluble growth stimulation expressed gene 2(sST2)and matrix metalloproteinase-29(MMP-29)in coronary heart disease patients with different degrees of coronary artery lesions.Methods:The medical records of 60 patients with coronary heart disease were collected as observation group.Meanwhile,the clinical data of 50 healthy individuals(control group)who received physical examinations were collected.Patients in the observation group were divided into unstable angina pectoris group,stable angina pectoris group and acute myocardial infarction group according to the type of the lesion displayed by coronary angiography.According to the number of lesions,the patients were divided into single-vessel disease group,double-vessel disease group and three-vessel disease group.According to Gensini score,the patients were divided into mild group,moderate group and severe group.Serum CyPA,sST2 and MMP-29 levels were compared between the observation group and the control group,among patients with different disease types,among patients with different numbers of lesions,and among patients with different degrees of disease.The diagnostic value of serum CyPA,sST2 and MMP-29 levels in coronary heart disease was analyzed.Results:Serum CyPA,sST2 and MMP-29 levels in the observation group were higher than those in the control group(all P<0.05).Serum CyPA,sST2 and MMP-29 levels decreased in sequence from the acute myocardial infarction group,the unstable angina pectoris group to the stable angina pectoris group(all P<0.05).Serum CyPA,sST2 and MMP-29 levels decreased in sequence from the three-vessel disease group,the double-vessel disease group to the single-vessel disease group(all P<0.05).Serum CyPA,sST2 and MMP-29 levels decreased in sequence from the sever group,the moderate group to the mild group(all P<0.05).Spearman correlation analysis found that serum CyPA,sST2 and MMP-29 levels were positively correlated with the severity of coronary heart disease(all P<0.05).ROC curve analysis showed that the area under curve(AUC)and specificity of serum CyPA for diagnosing coronary heart disease were higher than those of sST2 and MMP-29(all P<0.05).Conclusion:The higher the serum levels of CyPA,sST2 and MMP-29 in patients with coronary heart disease,the more severe the coronary artery disease.CyPA,sST2 and MMP-29 can be used for the diagnosis and evaluation of coronary heart disease.

参考文献/References:

[1] 王勇,武汉忠,常燕翔,等.冠心病患者主要不良心脏事件的相关因素及CTA相关参数的诊断价值研究[J].中国CT和MRI杂志,2023,21(8):82-84.
[2] 郭晓梅,刘艳军,黄春莉.中药复方穴位贴敷联合心可舒片治疗冠心病心绞痛临床研究[J].陕西中医,2023,44(2):255-258.
[3] 国家血管病中心.中国心血管健康与疾病报告2020[J].心肺血管病杂志,2021,40(10):1005-1009.
[4] 李贝贝.多元化健康教育联合理性情绪疗法在冠心病中应用价值探讨[J].罕少疾病杂志,2022,29(1):48-50.
[5] 南格利.冠心病颈动脉超声参数与斑块稳定性及炎症反应水平相关性分析[J].陕西医学杂志,2020,49(4):453-457.
[6] 宣玲,唐碧,康品方,等.冠心病病人血清亲环素A与冠状动脉病变程度的关系[J].蚌埠医学院学报,2021,46(8):1014-1016.
[7] 宋清华,张毅,陆元喜,等.血清RPs、sST2水平与冠心病冠脉介入患者预后相关性[J].中国煤炭工业医学杂志,2021,24(1):98-102.
[8] 甄宇治,宋适恒,邢军.芪苈强心胶囊联合托伐普坦片对冠心病慢性心力衰竭MMPs/TIMPs调节作用的研究[J].中华中医药学刊,2021,39(9):165-168.
[9] 马惠,常国栋,刘倩.心脉通胶囊治疗冠心病合并颈动脉粥样硬化疗效及对基质金属蛋白酶的影响[J].中国循证心血管医学杂志,2021,13(9):1112-1114.
[10] 张晶,周慧瑾.复方丹参滴丸联合氯吡格雷的疗效观察及对冠心病心绞痛患者血清白细胞介素6及白细胞介素10水平影响[J].药物生物技术,2021,28(1):70-73.
[11] 朱梦远,张翥,霍帅,等.视黄醇结合蛋白4与血液透析伴冠心病患者冠状动脉病变程度的相关性研究[J].中国临床医生杂志,2023,51(8):914-918.
[12] 刘恒,杨亚楠,于祯,等.芪苈强心胶囊联合沙库巴曲缬沙坦治疗对冠心病心力衰竭患者心功能及血清因子水平的影响[J].临床和实验医学杂志,2023,22(9):910-914.
[13] 郭雪,卢玉润.三种血清因子与冠心病严重程度的关系及诱发疾病的危险因素分析[J].中华老年心脑血管病杂志,2020,22(10):1050-1053.
[14] 吕琢,李秀琪,谢刚,等.血清亲环素A联合钙敏感受体对急性心肌梗死患者诊断价值分析[J].临床军医杂志,2021,49(9):1032-1037.
[15] 刘璐,张文彦,李世英.亲环素A和白细胞分化抗原147与动脉粥样硬化及缺血性心脑血管病的研究进展[J].心脑血管病防治,2021,21(5):488-491.
[16] 苏红燕,马衣热?耐比,曹晓青,等.亲环素A/CD147信号通路在心血管疾病中作用的研究进展[J].山东医药,2019,59(7):90-94.
[17] 王瑜硕,白洁,毛文娟,等.替格瑞洛联合阿托伐他汀对冠心病不稳定心绞痛患者的VEGF、TIMP-1及炎症指标水平的影响[J].海南医学,2019,30(24):3169-3172.
[18] 陈雨意,田鹏超,冯佳禹,等.即时检验(POCT)检测的sST2相关影响因素及其对心力衰竭的预后价值[J].中国循环杂志,2022,37(6):595-601.
[19] 王硕,齐云燕,王普,等.sST2水平与冠心病预后的相关性分析[J].昆明医科大学学报,2022,43(1):112-117.
[20] 田瑞兆,张春林,杨鹏,等.沙库巴曲缬沙坦联合美托洛尔对冠心病慢性心力衰竭患者心功能及血清sST2、AngⅡ、IGFBP7水平的影响[J].川北医学院学报,2022,37(1):59-62.
[21] 高健,王德琴,周永华,等.血清生长刺激表达基因2蛋白和脂蛋白相关磷脂酶A2与维持性血液透析患者心血管事件的关系[J].内科理论与实践,2022,17(4):295-300.
[22] 叶为,刘小燕,赵茂宇,等.慢性心力衰竭患者血清hsCRP,sST2水平与心脏再同步化治疗后室性心律失常的相关性[J].疑难病杂志,2023,22(6):566-571.
[23] 夏子梦,李静,凡栋.金属蛋白酶组织抑制剂在心血管疾病发病中的作用[J].生理科学进展,2022,53(2):88-94.
[24] ALI A N M,KAREEM S M,GHASEMIAN A.Assessment of MMP29 gene expression and silver nanoparticles effects on colon cancer cell line(HT29)[J].J Gastrointest Cancer,2020,51(2):560-563.
[25] 王叶宝,李建民.IL-18、MMP-22及MMP-29与老年冠心病冠状动脉病变的相关性研究[J].中国免疫学杂志,2021,37(12):1507-1512.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]汤克虎,高峻峰,任尽平.药物涂层球囊在糖尿病患者冠状动脉小血管病变治疗中的应用研究*[J].陕西医学杂志,2019,(4):432.
[3]马党捐 ,康彦智 ,柴茂林.64排128层螺旋CT冠状动脉成像在冠心病患者诊断中的价值研究*[J].陕西医学杂志,2019,(5):624.
　MA Dangjuan,KANG Yanzhi,CHAI Maolin..Value analysis of 64rows 128slice spiral CT coronary angiography in the diagnosis of patients with coronary heart disease[J].,2019,(7):624.
[4]沈 琳,马文苑.曲美他嗪联合氯吡格雷治疗冠心病心绞痛疗效及对患者心电图、血清超敏C反应蛋白和五聚素3的影响[J].陕西医学杂志,2019,(6):794.
　SHEN Lin,MA Wenyuan.ElectrocardiogramRoom,Therapeutic Effect ofTrimetazidine Combined with Clopidogrel on Angina Pectoris and its Hs-CRP[J].,2019,(7):794.
[5]杨延洁,周慧龙△.不同双抗血小板疗程对冠心病合并房颤PCI术后患者远期预后的影响*[J].陕西医学杂志,2019,(12):1653.
[6]魏 勇,梁 琪,左浩源,等.右美托咪定预处理对冠心病非心脏手术患者心肌的保护作用*[J].陕西医学杂志,2019,(12):1706.
　WEI Yong,LIANG Qi,ZUO Haoyuan,et al.Protective effect of dexmedetomidine preconditioning on myocardium in patients with coronary heart disease undergoing nonheart surgery[J].,2019,(7):1706.
[7]刘玉珊.心外膜脂肪定量及可溶性血栓调节蛋白与冠心病病变程度相关性分析[J].陕西医学杂志,2020,49(1):44.
　LIU Yushan..Correlation between the distribution of epicardial adipose tissue and soluble thrombomodulin and the severity of coronary heart disease[J].,2020,49(7):44.
[8]赵 博,王银谦,王红燕.巨噬细胞移动抑制因子与冠心病关系Meta分析[J].陕西医学杂志,2020,49(1):125.
[9]王亚平,彭春艳,朱名安Δ.冠心病合并代谢综合征患者固醇调节元件结合蛋白表达水平与脂代谢指标相关性研究*[J].陕西医学杂志,2020,49(4):419.
　WANG Yaping,PENG Chunyan,ZHU Mingan..Correlation between the levels of SREBPs and the indicators of lipid metabolism in patients with coronary heart disease complicated with metabolic syndrome[J].,2020,49(7):419.
[10]南格利.冠心病颈动脉超声参数与斑块稳定性及炎症反应水平相关性分析[J].陕西医学杂志,2020,49(4):453.
　NAN Geli..Correlation between carotid ultrasound parameters and plaque stability and inflammatory response in patients with coronary heart disease[J].,2020,49(7):453.
[11]金银浩,刘桂清.载脂蛋白AⅡ基因-265T/C多态性与冠心病患者脂类代谢及冠脉狭窄程度相关性研究[J].陕西医学杂志,2023,52(10):1331.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.010]
　JIN Yinhao,LIU Guiqing.Correlation between apolipoprotein AⅡ gene 265T/C polymorphism and lipid metabolism and degree of coronary stenosis in patients with coronary heart disease[J].,2023,52(7):1331.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.010]

备注/Memo

备注/Memo:
基金项目:四川省科技计划项目(2022YFS0260)
更新日期/Last Update: 2024-07-04